Advertisement
Screener

SPRINGWORKS THERAPEUTICS, INC. Increase (Decrease) in Inventories

SPRINGWORKS THERAPEUTICS, INC. Increase (Decrease) in Inventories

SPRINGWORKS THERAPEUTICS, INC. reported Increase (Decrease) in Inventories of $2.21 million for the 3-month period ending 2025-03-31, per its 10-Q filed 2025-05-09.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInInventories · last filed 2025-05-09

  • SPRINGWORKS THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2025-03-31 was $2.21M, a 4.35% increase year-over-year.
  • SPRINGWORKS THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-12-31 was $386.00K, a 87.56% decline year-over-year.
  • SPRINGWORKS THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-09-30 was $2.11M.
  • SPRINGWORKS THERAPEUTICS, INC. increase (decrease) in inventories for the quarter ending 2024-06-30 was $2.50M.
  • SPRINGWORKS THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2024 was $7.11M, a 129.10% increase from fiscal 2023.
  • SPRINGWORKS THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2023 was $3.10M.
  • SPRINGWORKS THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2022 was $0.00.
  • SPRINGWORKS THERAPEUTICS, INC. increase (decrease) in inventories for fiscal 2021 was $0.00.
Period endIncrease (Decrease) in Inventories 3 monthIncrease (Decrease) in Inventories 6 monthIncrease (Decrease) in Inventories 9 monthIncrease (Decrease) in Inventories 12 month
2025-03-31$2.21M
10-Q · filed 2025-05-09
$2.59M
derived: sum of 2 quarters · filed 2025-05-09
$4.70M
derived: sum of 3 quarters · filed 2025-05-09
$7.20M
derived: sum of 4 quarters · filed 2025-05-09
2024-12-31$386.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$2.49M
derived: sum of 2 quarters · filed 2025-02-20
$5.00M
derived: sum of 3 quarters · filed 2025-02-20
$7.11M
10-K · filed 2025-02-20
2024-09-30$2.11M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$4.61M
derived: sum of 2 quarters · filed 2024-11-12
$6.72M
10-Q · filed 2024-11-12
$9.83M
derived: sum of 4 quarters · filed 2025-05-09
2024-06-30$2.50M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$4.62M
10-Q · filed 2024-08-07
$7.72M
derived: sum of 3 quarters · filed 2025-05-09
$7.72M
derived: sum of 4 quarters · filed 2025-05-09
2024-03-31$2.11M
10-Q · filed 2025-05-09
$5.22M
derived: sum of 2 quarters · filed 2025-05-09
$5.22M
derived: sum of 3 quarters · filed 2025-05-09
$5.22M
derived: sum of 4 quarters · filed 2025-05-09
2023-12-31$3.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20
$3.10M
derived: sum of 2 quarters · filed 2025-02-20
$3.10M
derived: sum of 3 quarters · filed 2025-02-20
$3.10M
10-K · filed 2025-02-20
2023-09-30$0.00
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12
$0.00
derived: sum of 2 quarters · filed 2024-11-12
$0.00
10-Q · filed 2024-11-12
2023-06-30$0.00
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07
$0.00
10-Q · filed 2024-08-07
2023-03-31$0.00
10-Q · filed 2024-05-02
2022-12-31$0.00
10-K · filed 2025-02-20
2021-12-31$0.00
10-K · filed 2024-02-27